Novel prostaglandin receptor modulators – Part II: EP receptor modulators; a patent review (2002 – 2012)

Author： Flesch Daniel   Merk Daniel   Lamers Christina   Schubert-Zsilavecz Manfred  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.2, 2013-02, pp. : 233-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sigma receptor modulators: a patent review

By Collina Simona   Gaggeri Raffaella   Marra Annamaria   Bassi Andrea   Negrinotti Sara   Negri Francesca   Rossi Daniela  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 597-613

Informa Healthcare

Access to resources Recommend Favorite

AMPA receptor positive allosteric modulators: a patent review

By Pirotte Bernard   Francotte Pierre   Goffin Eric   de Tullio Pascal  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 615-628

Informa Healthcare

Access to resources Recommend Favorite

Latest discoveries in prostaglandin receptor modulators

By Dogné Jean-Michel   Leval Xavier de   Pirotte Bernard   Benoit Patricia  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 8, 2002-08 ,pp. : 1225-1235

Informa Healthcare

Access to resources Recommend Favorite

Toll-like receptor modulators: a patent review (2006 –– 2010)

By Basith Shaherin   Manavalan Balachandran   Lee Gwang   Kim Sang Geon   Choi Sangdun  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 6, 2011-06 ,pp. : 927-944

Informa Healthcare

Access to resources Recommend Favorite

Selective cannabinoid receptor 2 modulators: a patent review 2009 – present

By Riether Doris  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 495-510

Informa Healthcare

Access to resources Recommend Favorite